ArticleMolecular cancer therapeutics2026

PM534, a Novel Colchicine Site Tubulin Inhibitor with Broad-Spectrum and Resistance-Overcoming Antitumor Activity.

Pablo Aviles et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.